
VBIO vs ELAB
$VBIO vs $ELAB head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
VBIO vs ELAB: trend, levels and the market
One year to 2026-11-13, against the S&P 500 (+6%). Split-adjusted daily closes.
- ·Neither kept up with the market over the past year: VBIO -97.9% and ELAB -93.8%, against the S&P 500 at +6%.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
VBIO vs ELAB: the quick read
- ·ELAB is the larger company by market cap ($1M vs $1M).
- ·ELAB has been more active on our scanner (23 vs 4 alerts in 30 days).
- ·ELAB has the smaller float (1.2M vs 2.0M), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·ELAB draws far more of our scanner's attention, 23 unusual-volume alerts in 30 days against 4, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 15% of each other on market cap, which makes the rest of this table the interesting part.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
- ·They are pulling apart today: VBIO is outperforming the other by roughly 5.7 percentage points on the session.
Objective differences only. Not investment advice.
Watching VBIO or ELAB? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing VBIO and ELAB on TheDesperateTrader.
- Is VBIO or ELAB the better stock?
- "Better" depends on your goal, and these two are not alike. ELAB is the larger company by market cap ($1M vs $1M). ELAB has been more active on our scanner (23 vs 4 alerts in 30 days). ELAB has the smaller float (1.2M vs 2.0M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between VBIO and ELAB?
- The differences that matter: they are similar in size ($1M vs $1M); they trade at very different share prices ($0.54 vs $1.53); VBIO sits at 10% of its 52-week range against 1% for ELAB; our scanner flagged VBIO 4 times in the last 30 days against 23 for ELAB. Everything above is measured from the latest completed session and SEC filings.
- Which of VBIO and ELAB is more active right now?
- Right now VBIO is at about 0.0x its normal volume and ELAB is at about 0.1x, so ELAB is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is VBIO or ELAB in the stronger trend?
- VBIO is below its 50-day average of $1.66; ELAB is below its 50-day average of $3.26 and below its 200-day average of $25.36. ELAB leads 4 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading VBIO or ELAB? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.